Industry-university research contracts are damagingBMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e5978 (Published 18 September 2012) Cite this as: BMJ 2012;345:e5978
- David Packham, honorary fellow1
- 1Materials Research Centre, University of Bath, Bath BA2 7AY, UK
It is widely recognised that many prominent drug companies exert a nefarious effect on clinical research through abusing university sponsorship and confidentiality agreements in research contracts. Angell’s long editorial experience at the New England Journal of Medicine led her to comment “[i]t is simply no longer possible to believe much of the clinical research . . . published.”1
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial